论文部分内容阅读
目的探讨泌尿生殖道性传播感染者性伴的干预模式。方法将符合入选条件的100例门诊泌尿道衣原体感染者的性伴随机分为两组,分别进行性伴带药和性伴通知,在观察期结束后,对其干预的经济成本、干预的依从性和干预的效果进行比较。结果性伴带药组的平均干预经济成本为(170±12.3)元,依从性98%。性伴通知组,干预经济成本为(311±16.5)元,依从性73%。性伴带药组患者干预经济成本、依从性均优于性伴通知组(P<0.05),且两组的病菌清除率差异无统计学意义(P>0.05)。结论性伴带药具有经济成本低、依从性好的特点,能够有效阻断疾病的进一步传播。
Objective To explore the intervention model of sexual partners of genitourinary tract infection. Methods 100 cases of outpatients with genitourinary tract infection of Chlamydia trachomatis were randomly divided into two groups, respectively, with sexual partners and sexual partners notice, at the end of the observation period, the economic costs of intervention, intervention compliance Sexual and interventional effects are compared. The average cost of economic intervention was (170 ± 12.3) Yuan and the compliance was 98%. For the partner notification group, the economic cost of intervention was (311 ± 16.5) yuan and the compliance was 73%. The economic costs and compliance of the patients with sexual partners in the treatment group were better than those of the sexual partners group (P <0.05). There was no significant difference in the pathogenic bacteria clearance between the two groups (P> 0.05). Conclusions Sexually-associated drugs have the characteristics of low economic cost and good compliance, which can effectively stop the further spread of the disease.